Cost-effectiveness analysis of Champix® (varenicline) in smoking cessation treatment in Spain

被引：0
|
作者：
F Bobadilla, J. [1 ]
Brosa, M. [2 ,3 ]
Wilson, K.
Sánchez Maestre, C. [1 ]
机构：
[1] Pfizer Spain, Madrid, Spain
[2] Oblikue Consulting, Barcelona, Spain
[3] Pfizer European Brand Team, Surrey, England
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65620-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A471 / A472
页数：2
相关论文
共 50 条
  • [1] COST EFFECTIVENESS ANALYSIS OF VARENICLINE (CHAMPIX®) FOR THE TREATMENT OF SMOKING IN SPAIN
    de Bobadilla Osorio, J. Fernandez
    Sanchez-Maestre, C.
    Brosa Riestra, M.
    Arroyo, O.
    Sanz de Burgoa, V.
    Wilson, K.
    [J]. ANALES DE MEDICINA INTERNA, 2008, 25 (07) : 342 - 348
  • [2] THE COST-EFFECTIVENESS ANALYSIS OF VARENICLINE FOR SMOKING CESSATION IN POLAND
    Walczak, J.
    Nogas, G.
    Dybek-Karpiuk, A.
    Augustynska, J.
    Stelmachowski, J.
    Garbacka, M.
    Obrzut, G.
    Pawlik, D.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A303 - A303
  • [3] THE COST-EFFECTIVENESS OF VARENICLINE IN SMOKING CESSATION IN DENMARK
    Poulsen, P. B.
    Dollerup, J.
    Keiding, H.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A450 - A450
  • [4] Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation
    Javitz, Harold S.
    Zbikowski, Susan M.
    Deprey, Mona
    McAfee, Timothy A.
    McClure, Jennifer B.
    Richards, Julie
    Catz, Sheryl L.
    Jack, Lisa M.
    Swan, Gary E.
    [J]. TRANSLATIONAL BEHAVIORAL MEDICINE, 2011, 1 (01) : 182 - 190
  • [5] A cost-effectiveness model for smoking cessation therapy using varenicline
    Viswanathan, S.
    Neville, W.
    Patel, E.
    Raparla, S.
    McGhan, W. F.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A270 - A271
  • [6] Cost-Effectiveness Analysis of Varenicline Versus Currently Funded Smoking Cessation Strategies in Brazil
    Alves Fernandes, Ricardo Ribeiro
    Seixas, Brayan Viegas
    Szklo, Andre Salem
    Guerra, Renata Leborato
    Barufaldi, Laura Augusta
    Ribeiro de Albuquerque, Rita de Cassia
    de Mello Vianna, Cid Manso
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2022, 27 : 25 - 31
  • [7] A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
    Baker, Christine L.
    Pietri, Guilhem
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 67 - 74
  • [8] Cost-effectiveness analysis of treatment with varenicline for nicotine dependence compared with smoking cessation without pharmacotherapy in the real world
    Fujita, Takako
    Babazono, Akira
    Jiang, Peng
    Jamal, Aziz
    Li, Yunfei
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (02) : 187 - 195
  • [9] Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation
    Mahmoudi, M.
    Coleman, C. I.
    Sobieraj, D. M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (02) : 171 - 182
  • [10] COST-EFFECTIVENESS OF VARENICLINE COMPARED WITH BUPROPION AND NRT (NICORETTE) FOR SMOKING CESSATION IN AUSTRIA
    Walter, E.
    Mercsanits, D.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A563 - A563
12345